Search

everythinglearnresearchcommunity

for

Search:↓

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

A new combination of tadalafil and finasteride improves drug performance and stability.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Titagen® improves skin, hair, nail health, and reduces osteoarthritis symptoms safely.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Combining tadalafil and finasteride improves their solubility and effectiveness.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

MK-5108 is safe and shows potential against tumors, especially alone.

The combination treatment showed a higher response rate but no significant survival benefits.